2 Shanghai Key Laboratory of Vascular Lesions Regulation and Remodeling, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, Peoples Republic of China *These authors contributed equally to this work Correspondence: Ligang Zhou Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, 201399, Peoples Republic of China Tel +8613611927616 Email [email protected] Abstract: GLP-1 receptor agonists (GLP-1RAs) and SGLT-2 inhibitors (SGLT-2is) are novel antidiabetic medications associated with considerable cardiovascular benefits therapying treatment of diabetic patients
This makes it easier to ensure your B12 gets right into the muscle and not into the fat or lost somewhere in between
Brcic L, Iva B, Mario S, Novinscak T, Sikiric P, Seiwerth S
In contrast, injecting artificial GLP-1 gives you a much higher dose, that also lasts a lot longer